| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.01 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | 0.39 | 0.01 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.18 | 0.02 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | 0.091 | 0.02 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.02 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.02 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.09 | 0.02 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | 0.077 | 0.02 |